Vascular endothelial growth factor stimulates prostacyclin production and activation of cytosolic phospholipase A2 in endothelial cells via p42/p44 mitogen-activated protein kinase

FEBS Letters
C Wheeler-JonesI Zachary

Abstract

Vascular endothelial growth factor (VEGF) stimulated a time- and concentration-dependent increase in PGI2 synthesis in human umbilical vein endothelial cells with a mean maximum increase of 2-fold above basal levels at 25 ng/ml after 60 min. VEGF also rapidly stimulated the release of arachidonic acid and phosphorylation and activation of cytosolic phospholipase A2 (cPLA2). The VEGF-related factor, placenta growth factor (PIGF), had little effect on PGI2 synthesis, arachidonic acid release or cPLA2 activation. PD98059, a selective inhibitor of MAP kinase kinase, caused complete inhibition of VEGF-stimulated MAP kinase activity, PGI2 synthesis and cPLA2 gel retardation, but had no effect on VEGF-induced vWF secretion. These findings provide the first evidence that VEGF can stimulate PGI2 synthesis via cPLA2-mediated arachidonic acid release and indicate that VEGF stimulation of this biosynthetic pathway may occur, at least in part, via activation of p42/p44 MAP kinases.

References

Apr 1, 1992·Physiological Reviews·O HudlickaS Egginton
Jul 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·L L LinJ L Knopf
Aug 15, 1995·Proceedings of the National Academy of Sciences of the United States of America·D T DudleyA R Saltiel
Aug 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·T P QuinnL T Williams
Jan 29, 1993·Cell·L L LinR J Davis
Apr 17, 1997·Nature·W Risau
Jul 4, 1997·The Journal of Biological Chemistry·C C Leslie

❮ Previous
Next ❯

Citations

Mar 3, 2011·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Jincai LuoYao Lu
Apr 26, 2007·Angiogenesis·Carla CostaRaquel Soares
Feb 1, 2003·Lipids·Mariarosaria BoccellinoLucio Quagliuolo
Feb 1, 2005·The American Journal of Pathology·Ping ChenA Guillermo Scicli
Jun 15, 1999·Prostaglandins & Other Lipid Mediators·C FimianiG B Stefano
Jul 27, 2001·Molecular Aspects of Medicine·G M Rubanyi
Feb 16, 2000·Lancet·S Ylä-Herttuala, J F Martin
Apr 3, 2001·Trends in Pharmacological Sciences·M J Cross, L Claesson-Welsh
Dec 5, 1998·The International Journal of Biochemistry & Cell Biology·I Zachary
Mar 5, 2003·Trends in Molecular Medicine·Miguel A IñiguezJuan Miguel Redondo
May 16, 2003·Vascular Pharmacology·D O Bates, S J Harper
Apr 11, 2009·Tissue Engineering. Part a·Duc M VuTakayuki Asahara
Aug 12, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Paolo FabbriniJaap van den Born
Sep 29, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Yong-Lim KimChan-Duck Kim
May 21, 2010·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Hye In LeeKye Yong Song
Aug 2, 2012·Hypertension·Nilka de Jesus-GonzalezBenjamin D Humphreys
Feb 26, 2003·American Journal of Respiratory Cell and Molecular Biology·Rubin M TuderSonia C Flores
Sep 21, 2000·The Journal of Clinical Investigation·N F Voelkel, R M Tuder
Aug 23, 2000·The Journal of Clinical Investigation·Y HataL P Aiello
Aug 4, 2009·Reproductive Biology and Endocrinology : RB&E·Gloria ValdesJanae Joyner-Grantham
Jun 2, 2011·Cardiology Research and Practice·Carmen P Escalante, Ali Zalpour

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.